Discover the events where Ozabio will be participating and showcasing its innovations.
Ozabio will be exhibiting at Vitafoods Europe 2026, showcasing its latest innovations and advancements in liposomal and nutraceutical technologies. Visit us at Stall No. 3B260 to learn more about our solutions.
Take a look at the events and exhibitions where Ozabio has previously participated and connected with industry professionals.
Ozabio will be exhibiting at Vitafoods Europe 2026, showcasing its latest innovations and advancements in liposomal and nutraceutical technologies. Visit us at Stall No. 3B260 to learn more about our solutions.
Ozabio will be exhibiting at Vitafoods Europe 2026, showcasing its latest innovations and advancements in liposomal and nutraceutical technologies. Visit us at Stall No. 3B260 to learn more about our solutions.
Ozabio will be exhibiting at Vitafoods Europe 2026, showcasing its latest innovations and advancements in liposomal and nutraceutical technologies. Visit us at Stall No. 3B260 to learn more about our solutions.
Have questions about our products or services? Reach out to us and our team will be happy to assist you with the right information and support.
Phone: +91 78769 66742, +1 (571)315-3939, +971 52 156 2603
Mail: [email protected]
Location: 1207 Delaware Ave #2877, Wilmington DE 19806, USA
© 2026 OzaBio | All Rights Reserved.
WhatsApp us
Fill out the form below and our team will get back to you within 24–48 business hours.
Dynamic Light Scattering (DLS) is employed to evaluate the particle size distribution and polydispersity of liposomal formulations, providing essential information on colloidal stability, dispersion uniformity, and potential bioavailability.
For example – Lipoza®-Curcumin
Caco-2 studies utilize human intestinal epithelial cell monolayers to evaluate the permeability and predicted absorption of test substances across the gut barrier.
For example – Lipoza-Glutathione
Demonstrated superior permeability, showing 0.95% transport compared to 0.29% for Reduced L-Glutathione—an approximate 3.28-fold increase. This enhanced permeability, despite lower glutathione content, indicates improved intestinal absorption and supports its potential as a more bioavailable form of glutathione supplementation.
Fill out the form below and we'll get back to you soon
* indicates required question